Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

By afschroeder • August 7, 2025

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening - The VICTORION-PLAQUE primary prevention trial. Am Heart J. 2025 Aug 4:S0002-8703(25)00291-1. doi: 10.1016/j.ahj.2025.08.001. Epub ahead of print. PMID: 40769373.

Tags: Cardiology/Epi, CCTA derived Fractional Flow Reserve (FFR(CT)), coronary computed tomography angiography (CCTA), CT-adapted Leaman score, Harbor UCLA, Inclisiran, Low density Lipoprotein Cholesterol (LDL-C), non-obstructive coronary artery disease (NOCAD), Publications, total atheroma volume (TAV)

Coronary Plaque Burden and Progression in Los Angeles Firefighters Versus Matched Controls: A Cohort Study

Hoque A, Kinninger A, Roy SK, Budoff M. Coronary Plaque Burden and Progression in Los Angeles Firefighters Versus Matched Controls: A Cohort Study. J Occup[...]

Development and Validation of a Coronary Artery Calcium Volume and Density Score

Bhatia HS, Razavi AC, Dardari Z, McClelland RL, Jacobs DR Jr, Terry JG, Carr JJ, Duprez D, Joshi PH, Rohatgi A, Khera A, Rana JS,[...]

Oral Anticoagulant Monotherapy vs. Combination Therapy in Chronic Coronary Syndrome Requiring Long-Term Anticoagulation: An Updated Meta-Analysis of Randomized Controlled Trials

Sarwar M, Daniyal SM, Noor A, Riaz M, Batool F, Gondal HT, Murad Khatoon N, Fahim SL, Aftab Z, Ajaz H, Gul I, Khalid A,[...]